Not Medicare Enrolled

Dr. Fahim Khorfan, M.D.

Pulmonary Disease · Burton, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1513 S CENTER RD, Burton, MI 48509
8107420224
Registered in NPPES since 2006
NPI: 1497867931 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khorfan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khorfan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khorfan

Dr. Fahim Khorfan is a pulmonary disease specialist in Burton, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khorfan performed 471 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Khorfan received a total of $6,381 from 44 pharmaceutical and/or device companies across 374 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khorfan is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 471 Medicare services $6,381 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
471
Medicare services
Bottom 38% in MI for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
140 $58 $112
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
88 $84 $168
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
66 $25 $300
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
47 $23 $70
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
42 $37 $113
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
42 $41 $117
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
33 $22 $194
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $73 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,381
Total received (2018-2024)
Avg $912/year across 7 years
Top 21% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
374
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$90
2023
$445
2022
$1,368
2021
$1,633
2020
$937
2019
$969
2018
$939

Payments by company (2024)

GENZYME CORPORATION
$38
Philips North America LLC
$30
Mallinckrodt Hospital Products Inc.
$22
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,129
GlaxoSmithKline, LLC.
$921
Insmed, Inc.
$462
Boehringer Ingelheim Pharmaceuticals, Inc.
$450
Genentech USA, Inc.
$364
Actelion Pharmaceuticals US, Inc.
$282
GENZYME CORPORATION
$210
Novartis Pharmaceuticals Corporation
$202
MAYNE PHARMA INC.
$192
Harmony Biosciences LLC
$155
Philips Electronics North America Corporation
$137
Regeneron Healthcare Solutions, Inc.
$117
Inogen, Inc.
$114
Janssen Pharmaceuticals, Inc
$112
Mylan Specialty L.P.
$112
United Therapeutics Corporation
$105
Gilead Sciences, Inc.
$102
Teva Pharmaceuticals USA, Inc.
$89
CSL Behring
$89
JAZZ PHARMACEUTICALS INC.
$77
Bayer HealthCare Pharmaceuticals Inc.
$70
Mallinckrodt Hospital Products Inc.
$69
Mallinckrodt LLC
$64
Intuitive Surgical, Inc.
$60
Advanced Respiratory, Inc
$60
Grifols USA, LLC
$60
Resmed Corp
$59
Jazz Pharmaceuticals Inc.
$56
Electromed, Inc.
$47
ABBVIE INC.
$45
Amgen Inc.
$40
Melinta Therapeutics, LLC
$39
Circassia Pharmaceuticals Inc
$38
Bayer Healthcare Pharmaceuticals Inc.
$36
Sunovion Pharmaceuticals Inc.
$35
Pulmonx Corporation
$34
Philips North America LLC
$30
Shire North American Group Inc
$28
Allergan Inc.
$25
ADVANCED RESPIRATORY, INC
$15
Paratek Pharmaceuticals, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
PFIZER INC.
$12
Allergan, Inc.
$12
Top 3 companies account for 39.4% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSENSE · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · AirDuo Digihaler · AirFit · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · CHANTIX · CHARTIS CATHETER · CINQAIR · DALIRESP · DUPIXENT · Da Vinci Surgical System · Esbriet · FARXIGA · FASENRA · GLASSIA · Haegarda · Hizentra · INOGEN · InogenOne · Kcentra · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Orbactiv · POMPE - DISEASE · Prolastin-C Liquid · QVAR · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Burton?
Compare pulmonary diseases in the Burton area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
19
County median income
$60,673
Nearest hospital to ZIP centroid (approximate)
HURLEY MEDICAL CENTER
5.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khorfan is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khorfan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Khorfan performed 140 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khorfan receive payments from pharmaceutical companies?
Yes. Dr. Khorfan received a total of $6,381 from 44 companies across 374 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khorfan's costs compare to other pulmonary diseases in Burton?
Dr. Khorfan's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Khorfan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →